<DOC>
	<DOCNO>NCT01001117</DOCNO>
	<brief_summary>The use femtosecond laser cataract surgery give equivalent improve result comapred conventional phaco-emulsification surgery .</brief_summary>
	<brief_title>Laser Treatment Crystalline Lens</brief_title>
	<detailed_description>The objective study evaluate feasibility LensAR laser system surgically intervene within crystalline lens . The primary goal initial study establish safety parameter compare conventional phacoemulsification procedure , evaluate ability provide accurate consistent anterior capsular opening ( capsulotomy ) .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Subjects must sign give copy write informed consent form . Subjects must elect undergo lens extraction foldable monofocal IOL implantation ( ideally type ) , elect LensAR laser surgery . Subjects must willing able return schedule followup examination minimum 12 month surgery . Central 8 mm clear cornea without vascularization . Subjects prior anterior segment vitreoretinal surgical intervention eye treat . Subjects lenticular cataract nuclear grade great Grade 4 LOCS III scale . Subjects attain ocular dilation 7.0 mm . Subjects anterior segment pathology eye treat directly improve lens extraction IOL implantation . Subjects residual , recurrent , active ocular uncontrolled eyelid disease corneal abnormality ( include endothelial dystrophy , guttata , recurrent corneal erosion , etc . ) eye treat . Subjects ophthalmoscopic sign keratoconus ( keratoconus suspect ) eye treat . Subjects history severe dry eye respond therapy . Subjects macular degeneration , history retinal detachment , fundus finding would pose risk safety acceptable visual outcome eye treat . Subjects history herpes zoster herpes simplex keratitis . Subjects history steroidresponsive rise intraocular pressure , glaucoma , glaucoma suspect . Subjects diabetic retinopathy , autoimmune disease , connective tissue disease , pseudoexfoliation syndrome , clinically significant atopic syndrome . Subjects chronic systemic corticosteroid immunosuppressive therapy may affect wound healing , immunocompromised subject . Subjects use ophthalmic medication ( ) artificial tear treatment ocular pathology include ocular allergy . Subjects use systemic medication significant ocular side effect . Subjects pregnant , lactating , childbearing potential practicing medically approve method birth control . Subjects know sensitivity plan study concomitant medication . Subjects participate ophthalmic drug device clinical trial time clinical investigation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Cataract</keyword>
	<keyword>Capsulotomy</keyword>
	<keyword>Capsulorrhexis</keyword>
	<keyword>Phacoemulsification</keyword>
</DOC>